Elsevier

Journal of Cardiac Failure

Volume 2, Issue 3, September 1996, Pages 223-240
Journal of Cardiac Failure

Review
Pathophysiologic and therapeutic implicationsof sleep apnea in congestive heart failure*

https://doi.org/10.1016/S1071-9164(96)80045-5Get rights and content

Abstract

Obstructive and central sleep apnea are common in patients with congestive heart failure(CHF). These sleep-related breathing disorders are characterized by two pathophysiologic features that could have important implications for disease progression in CHF: sympathetic nervous system activation, and adverse changes in cardiac loading conditions. In patients with obstructive sleep apnea, blood pressure is frequently elevated as a result of excessive sympathetic nervous system activity elicited by the combination of apnea, hypoxia, and arousals from sleep. The generation of exaggerated negative intrathoracic pressure during obstructive apneas further increases left ventricular afterload, reduces cardiac output, and may promote the progression of pump failure. Increased afterload and hypoxia can also predispose such patients to myocardial ischemia and arrhythmias. In patients with CHF, abolition of coexisting obstructive sleep apnea by nasal continuous positive airway pressure improves left ventricular function. Central sleep apnea (ie, Cheyne-Stokes respiration) is also characterized by apnea, hypoxia, and increased sympathetic nervous system activity and, when present in CHF, is associated with increased risk of death. Recent medium-term trials involving small numbers of patients have demonstrated that nocturnally applied continuous positive airway pressure in patients with CHF and central sleep apnea alleviates central sleep apnea, improves left ventricular function, reduces sympathetic nervous system activity and improves symptoms of CHF. These studies emphasize the importance of considering obstructive and central sleep apnea in the differential diagnosis of conditions that could contribute to the development or progression of CHF. They also suggest that continuous positive airway pressure is a promising nonpharmacologic adjunctive therapy for patients with CHF and coexisting sleep-related breathing disturbances that warrants further investigation.

References (150)

  • SomersV.K. et al.

    Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans

    J Auton Nerv Syst

    (1993)
  • ShimizuT. et al.

    Muscle sympathetic nerve activity during apneic episodes in patients with obstructive sleep apnea syndrome

    Electroencephalogr Clin Neurophysiol

    (1994)
  • LouiW.S. et al.

    Obstructive sleep apnea manifesting as suspected angina: report of three cases

  • MiddlekauffH.R. et al.

    Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope

    J Am Coll Cardiol

    (1993)
  • CarlsonJ.T. et al.

    Augmented resting sympathetic activity in awake patients with obstructive sleep apnea

    Chest

    (1993)
  • FergusonD.W. et al.

    Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings

    J Am Coll Cardiol

    (1990)
  • KayeD.M. et al.

    Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure

    J Am Coll Cardiol

    (1994)
  • ShepardJ.W. et al.

    Relationship of ventricular ectopy and oxyhemoglobin desaturation in patients with obstructive sleep apnea

    Chest

    (1985)
  • ShepardJ.W.

    Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea

    Clin Chest Med

    (1992)
  • HanlyP. et al.

    Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure: relationship to arterial Pco2

    Chest

    (1993)
  • American College of Cardiology/American Heart Association Task Force

    Report: guidelines for the evaluation and management of heart failure

    J Am Coll Cardiol

    (1995)
  • YusufS. et al.

    Changes in hypertension treatment and congestive heart failure mortality in the United States

    Hypertension

    (1989)
  • SOLVD Investigators

    Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure

    N Engl J Med

    (1991)
  • NaughtonM.T. et al.

    Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure

    Am J Respir Crit Care Med

    (1995)
  • JavaheriS. et al.

    Occult sleep-disordered breathing in stable congestive heart failure

    Ann Intern Med

    (1995)
  • FindleyL.J. et al.

    Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure

    South Med J

    (1985)
  • HanlyP.J. et al.

    Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure

    Am J Respir Crit Care Med

    (1996)
  • MaloneS. et al.

    Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure

    Lancet

    (1991)
  • TakasakiY. et al.

    Effect of nasal continuous positive airway pressure on sleep apnea in congestive heart failure

    Am Rev Respir Dis

    (1989)
  • NaughtonM.T. et al.

    Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea

    Am J Respir Crit Care Med

    (1995)
  • GrantonJ.T. et al.

    CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea

    Am J Respir Crit Care Med

    (1996)
  • DecG.W. et al.

    Medical progress: idiopathic dilated cardiomyopathy

    N Engl J Med

    (1994)
  • BenardD.C. et al.

    Administration of continuous positive airway pressure to patients with congestive heart failure and Cheyne-Stokes respiration

    J Polysomnogr

    (1992)
  • BradleyT.D. et al.

    Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome

    Am Rev Respir Dis

    (1985)
  • BradleyT.D.

    Breathing during sleep in cardiac disease

  • StradlingJ.R.

    Sleep apnoea and systemic hypertension

    Thorax

    (1989)
  • NortonP.G. et al.

    Snoring as a risk factor for disease: an epidemiological survey

    Br Med J

    (1985)
  • KoskenvuoM. et al.

    Snoring as a risk factor for ischaemic heart disease and stroke in men

    Br Med J

    (1987)
  • CarlsonJ.T. et al.

    High prevalence of hypertension in sleep apnea patients independent of obesity

    Am J Respir Crit Care Med

    (1994)
  • HlaK.M. et al.

    Sleep apnea and hypertension: a population-based study

    Ann Intern Med

    (1994)
  • Galatius-JensenS. et al.

    Nocturnal hypoxaemia after myocardial infarction: association with nocturnal myo cardial ischaemia and arrhythmias

    Br Heart J

    (1994)
  • YoungT.B. et al.

    The occurrence of sleep-disordered breathing among middle-aged adults

    N Engl J Med

    (1993)
  • WhiteD.P. et al.

    Metabolic rate and breathing during sleep

    J Appl Physiol

    (1985)
  • SomersV.K. et al.

    Sympathetic-nerve activity during sleep in normal subjects

    N Engl J Med

    (1993)
  • HornyakM. et al.

    Sympathetic muscle nerve activity during sleep in man

    Brain

    (1991)
  • FurlanR. et al.

    Continuous 24-hour assessment of neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects

    Circulation

    (1990)
  • DaviesR.J. et al.

    Arterial blood pressure responses to graded transient arousal from sleep in normal humans

    J App] Physiol

    (1993)
  • PhillipsonE.A. et al.

    Control of breathing during sleep

  • OremJ. et al.

    Activity of respiratory neurons during NREM sleep

    J Neurophysiol

    (1985)
  • XieA. et al.

    Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea

    Am J Respir Crit Care Med

    (1994)
  • Cited by (83)

    • Assessment of respiratory disturbance index determined with a non-restrictive monitor and of autonomic nervous system parameters in heart failure patients: A pilot study

      2015, Journal of Cardiology
      Citation Excerpt :

      Recent data suggest that sleep apnea can lead to the progression of cardiac dysfunction in patients with chronic heart failure [17]. This adverse effect on cardiac function probably arises from repetitive apneas causing arterial oxyhemoglobin desaturation and excessive stimulation of the sympathetic nervous system [17,18]. Javaheri et al. [19] reported that moderate to severe SDB (RDI ≥15 events/h) was present in 51% (40% CSA and 11% OSA) of male patients with stable heart failure, and Oldenburg et al. [20] showed that it was present in 76% of patients (40% CSA and 36% OSA) with symptomatic chronic heart failure.

    • Sleep-Related Breathing Disorders in the Elderly

      2006, Sleep Medicine Clinics
      Citation Excerpt :

      Sleep-related respiration in older populations may differ than that in younger populations, however, and these differences may justify consideration of alternative indices to characterize SDB best in older populations. For example, underlying cardiovascular and neurologic disorders [22] or diabetes [23] in older individuals may increase the prevalence of Cheyne-Stokes breathing, which is associated with an increased frequency of central apnea. Quantification of central apnea by calculating a distinct central apnea index may facilitate identification of subgroups of the elderly with SDB whose disorder is substantively influenced by underlying medical problems, and whose primary breathing disturbances may have differing physiologic effects than individuals with predominantly obstructive events (ie, by high levels of obstructive apnea and hypopnea and few central events).

    • International Consensus Statement on Obstructive Sleep Apnea

      2023, International Forum of Allergy and Rhinology
    View all citing articles on Scopus
    *

    Supported by operating grants from the Medical Research Council of Canada and the Heart and Stroke Foundation of Ontario.

    View full text